Automated CRISPR-Cas12a Genomic Target Enrichment Foundry Cap Rate 2026

Underwrite GMP Class A/B continuous synthetic enAsCas12a collateral cleavage diagnostic arrays and long-read targeted genomic sequencing vector suites, $565/sqft base lease rates, and exit cap rates.